AAGH (America Great Health) FCF Margin % : 110.64% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is America Great Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. America Great Health's Free Cash Flow for the three months ended in Mar. 2024 was $0.10 Mil. America Great Health's Revenue for the three months ended in Mar. 2024 was $0.09 Mil. Therefore, America Great Health's FCF Margin % for the quarter that ended in Mar. 2024 was 110.64%.

As of today, America Great Health's current FCF Yield % is -30.96%.

The historical rank and industry rank for America Great Health's FCF Margin % or its related term are showing as below:

AAGH' s FCF Margin % Range Over the Past 10 Years
Min: -1425.71 Med: -390.69 Max: -160.47
Current: -239.42

During the past 13 years, the highest FCF Margin % of America Great Health was -160.47%. The lowest was -1425.71%. And the median was -390.69%.

AAGH's FCF Margin % is ranked worse than
56.75% of 1045 companies
in the Biotechnology industry
Industry Median: -145.32 vs AAGH: -239.42

America Great Health FCF Margin % Historical Data

The historical data trend for America Great Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

America Great Health FCF Margin % Chart

America Great Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

-800.00

-174.49

-1,425.71

-390.69

America Great Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-517.95	-446.67	-864.29	-334.07	110.64

Competitive Comparison of America Great Health's FCF Margin %

For the Biotechnology subindustry, America Great Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

America Great Health's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, America Great Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where America Great Health's FCF Margin % falls into.

America Great Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

America Great Health's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-0.797	/	0.204
	=	-390.69 %

America Great Health's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0.104	/	0.094
	=	110.64 %

America Great Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of America Great Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

America Great Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » America Great Health (OTCPK:AAGH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1609 W Valley Boulevard, Unit 338A, Alhambra, CA, USA, 91803

Website

http://www.aaghus.com

America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.

America Great Health Headlines

No Headlines